Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice

Jeffrey B. Boord, Kazuhisa Maeda, Liza Makowski, Vladimir R. Babaev, Sergio Fazio, MacRae F. Linton, Gökhan S. Hotamisligil

Research output: Contribution to journalArticle

142 Citations (Scopus)

Abstract

Background-The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metabolism, and atherosclerosis. Insulin sensitivity is improved in obese but not in lean aP2-deficient mice. A second fatty acid-binding protein, mall, also is expressed in adipocytes and macrophages, and mall deficiency produces similar effects on insulin resistance. We tested the hypothesis that combined aP2 and mall deficiency would produce synergistic effects on metabolism and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice. Methods and Results-Male and female apoE-/- mice null for both aP2 and mall (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 weeks. Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls. Analysis of atherosclerotic lesions in the 3KO mice showed dramatic reductions in both early (20 weeks) and late-stage (60 weeks) atherosclerosis. Strikingly, survival in the 3KO mice was improved by 67% as compared with apoE-/- controls when challenged with the Western diet for 1 year. Conclusions-Combined aP2 and mall deficiency improved glucose and lipid metabolism, reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)1492-1498
Number of pages7
JournalCirculation
Volume110
Issue number11
DOIs
StatePublished - Sep 14 2004
Externally publishedYes

Fingerprint

Protein Deficiency
Fatty Acid-Binding Proteins
Apolipoproteins E
Adipocytes
Atherosclerosis
Macrophages
Insulin Resistance
Lipid Metabolism
Glucose
Metabolic Syndrome X
Fat-Restricted Diet
Triglycerides
Cholesterol
Insulin
Serum

Keywords

  • Atherosclerosis
  • Macrophages
  • Metabolism
  • Syndrome X

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. / Boord, Jeffrey B.; Maeda, Kazuhisa; Makowski, Liza; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Hotamisligil, Gökhan S.

In: Circulation, Vol. 110, No. 11, 14.09.2004, p. 1492-1498.

Research output: Contribution to journalArticle

Boord, Jeffrey B. ; Maeda, Kazuhisa ; Makowski, Liza ; Babaev, Vladimir R. ; Fazio, Sergio ; Linton, MacRae F. ; Hotamisligil, Gökhan S. / Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. In: Circulation. 2004 ; Vol. 110, No. 11. pp. 1492-1498.
@article{a389dcf83300460a8bcbfd9d73451f57,
title = "Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice",
abstract = "Background-The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metabolism, and atherosclerosis. Insulin sensitivity is improved in obese but not in lean aP2-deficient mice. A second fatty acid-binding protein, mall, also is expressed in adipocytes and macrophages, and mall deficiency produces similar effects on insulin resistance. We tested the hypothesis that combined aP2 and mall deficiency would produce synergistic effects on metabolism and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice. Methods and Results-Male and female apoE-/- mice null for both aP2 and mall (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 weeks. Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls. Analysis of atherosclerotic lesions in the 3KO mice showed dramatic reductions in both early (20 weeks) and late-stage (60 weeks) atherosclerosis. Strikingly, survival in the 3KO mice was improved by 67{\%} as compared with apoE-/- controls when challenged with the Western diet for 1 year. Conclusions-Combined aP2 and mall deficiency improved glucose and lipid metabolism, reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.",
keywords = "Atherosclerosis, Macrophages, Metabolism, Syndrome X",
author = "Boord, {Jeffrey B.} and Kazuhisa Maeda and Liza Makowski and Babaev, {Vladimir R.} and Sergio Fazio and Linton, {MacRae F.} and Hotamisligil, {G{\"o}khan S.}",
year = "2004",
month = "9",
day = "14",
doi = "10.1161/01.CIR.0000141735.13202.B6",
language = "English (US)",
volume = "110",
pages = "1492--1498",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice

AU - Boord, Jeffrey B.

AU - Maeda, Kazuhisa

AU - Makowski, Liza

AU - Babaev, Vladimir R.

AU - Fazio, Sergio

AU - Linton, MacRae F.

AU - Hotamisligil, Gökhan S.

PY - 2004/9/14

Y1 - 2004/9/14

N2 - Background-The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metabolism, and atherosclerosis. Insulin sensitivity is improved in obese but not in lean aP2-deficient mice. A second fatty acid-binding protein, mall, also is expressed in adipocytes and macrophages, and mall deficiency produces similar effects on insulin resistance. We tested the hypothesis that combined aP2 and mall deficiency would produce synergistic effects on metabolism and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice. Methods and Results-Male and female apoE-/- mice null for both aP2 and mall (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 weeks. Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls. Analysis of atherosclerotic lesions in the 3KO mice showed dramatic reductions in both early (20 weeks) and late-stage (60 weeks) atherosclerosis. Strikingly, survival in the 3KO mice was improved by 67% as compared with apoE-/- controls when challenged with the Western diet for 1 year. Conclusions-Combined aP2 and mall deficiency improved glucose and lipid metabolism, reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.

AB - Background-The adipocyte fatty acid-binding protein (FABP) aP2 is expressed by adipocytes and macrophages and modulates insulin resistance, glucose and lipid metabolism, and atherosclerosis. Insulin sensitivity is improved in obese but not in lean aP2-deficient mice. A second fatty acid-binding protein, mall, also is expressed in adipocytes and macrophages, and mall deficiency produces similar effects on insulin resistance. We tested the hypothesis that combined aP2 and mall deficiency would produce synergistic effects on metabolism and reduce atherosclerosis in apolipoprotein E-deficient (apoE-/-) mice. Methods and Results-Male and female apoE-/- mice null for both aP2 and mall (3KO) and apoE-/- controls were fed a low-fat chow diet for 16 or 56 weeks. Lean 3KO mice had significantly lower serum cholesterol and triglycerides as well as improved insulin and glucose tolerance as compared with controls. Analysis of atherosclerotic lesions in the 3KO mice showed dramatic reductions in both early (20 weeks) and late-stage (60 weeks) atherosclerosis. Strikingly, survival in the 3KO mice was improved by 67% as compared with apoE-/- controls when challenged with the Western diet for 1 year. Conclusions-Combined aP2 and mall deficiency improved glucose and lipid metabolism, reduced atherosclerosis, and improved survival in apoE-/- mice, making these proteins important therapeutic targets for the prevention of the cardiovascular consequences of the metabolic syndrome.

KW - Atherosclerosis

KW - Macrophages

KW - Metabolism

KW - Syndrome X

UR - http://www.scopus.com/inward/record.url?scp=4544298808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544298808&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000141735.13202.B6

DO - 10.1161/01.CIR.0000141735.13202.B6

M3 - Article

VL - 110

SP - 1492

EP - 1498

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 11

ER -